Bioanalytical
Mass spectrometry could solve pharma riddle
Jun 15 2010
While the amino-termini of protein clippings have been successfully analysed, pharma researchers have thus far failed to find a satisfactory way to investigate the clippings' other ends.
However, mass spectrometry may provide the answer, as scientists at Albert-Ludwigs-Universitaet Freiburg have revealed.
The discovery could hold promise for the research of medical conditions - such as the role of cathepsin proteases in cancer development.
Using mass spectrometry as part of a multi-stage process, the scientists identified carboxy-terminal sequences following proteolysis.
They claim to have unearthed a relatively high rate of proteolysis, as 40 per cent of carboxy-termini identified are believed to have been created through molecular cleavage.
The University recently hosted a conference of about 350 scientists who discussed issues relating to systems biology and, in particular, generalising research at the cellular level to be applied to whole mammalian organisms.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
May 15 2024 Birmingham, UK